甜菊糖配糖体的全球市场

到 2030 年，全球配糖体市场规模将达到 66 亿美元

全球甜菊糖配糖体市场规模预计在2024年为51亿美元，预计到2030年将达到66亿美元，2024年至2030年的复合年增长率为4.3%。甜菊双糖苷是本报告分析的细分市场之一，预计其复合年增长率为3.2%，到分析期结束时规模将达到27亿美元。甜菊苷细分市场在分析期间的复合年增长率预计为5.6%。

美国市场规模估计为 14 亿美元，中国市场预计复合年增长率为 7.6%

美国甜菊糖配糖体市场规模预计2024年达到14亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到13亿美元，在2024-2030年的分析期间内，复合年增长率为7.6%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.8%和3.3%。在欧洲，预计德国市场的复合年增长率为2.5%。

全球甜菊糖配糖体市场－主要趋势与驱动因素摘要

是什么推动了对甜菊糖配糖体作为天然甜味剂的需求？

甜菊糖配糖体——甜菊糖 (Stevia rebaudiana)，植物来源的天然甜味剂——作为糖的替代品正迅速获得认可。甜菊糖苷零卡路里，同时保持高甜度，越来越多地用于饮料、糖果甜点、乳製品替代品和餐桌甜味剂。製造商和政府正在转向使用甜菊糖来减少糖分，以对抗肥胖和糖尿病。这种转变使甜菊糖配糖体成为洁净标示食品行业的首选天然成分。萃取产业已经成熟，现在可以使用溶剂和水基製程来生产高纯度的莱鲍迪苷 A 变体（例如 Reb A、Reb D 和 Reb M）。这些改进有助于克服与较老的甜菊萃取物有关的挥之不去的口味问题，例如苦涩的余味。

口味增强和配方技术是否正在发展？

使用 Reb M 和 Reb D 味噌混合物的创新口味改良方法，可减少苦味并改善口感。遮罩味、包封技术和pH值调节技术使其能够相容于酸性饮料和耐热应用。透明糖浆和混合物针对气泡水、即饮饮料和酵母菌饮料进行了最佳化。包封技术确保其在干混料中均匀溶解。甜菊糖配糖体与其他甜味剂（例如赤藻醣醇、阿洛酮糖）的混合物可提供类似糖的口感，从而扩展了产品的多功能性。

为什么製造商更喜欢甜菊糖配糖体？

健康和监管要求推动包装食品和儿童食品中糖含量的减少，这使得甜菊糖成为必不可少的成分。偏好越来越倾向于天然植物来源成分，而非合成成分。标榜「无添加糖」、「零卡路里」或「无糖」的食品都依赖甜菊糖作为甜味剂。在主要出口国进行受控的甜菊糖种植，可以提高供应链的韧性。品牌受益于FCC食品级纯度标准，并在受监管市场更快获得产品核可。

推动甜菊糖配糖体市场成长的因素是什么？

甜菊糖配糖体市场的成长受到多种因素的驱动，这些因素与应用领域的拓展、口味的改进以及监管力度的加强有关。新型高纯度莱鲍迪苷变体解决了以往的味觉障碍，使其在饮料、乳製品和烘焙食品中的应用范围不断扩大。遮罩味和封装技术方面的投资不断增加，也改善了配方。主要经济体的公共卫生计划和糖税推动了需求成长。甜菊糖苷已被监管机构广泛接受，在美国获得GRAS认证，并在欧盟、印度和拉丁美洲核准。种植者、加工商和品牌之间的供应链伙伴关係正在增强产品的可追溯性和一致性。

部分

类型（甜菊糖苷、甜菊苷、莱鲍迪苷 A、莱鲍迪苷 B）、加工方法（基于发酵的方法、基于水产养殖的方法）、最终用户（食品和饮料、製药、化学品）

受访公司范例

• ADM（Archer Daniels Midland）
• Blue California
• Cargill, Incorporated
• DSM（Koninklijke DSM NV）
• Evolva
• Fujifilm Wako Pure Chemical Corporation
• GLG Life Tech Corp.（GL Stevia）
• Ingredion Incorporated
• Kerry Inc.
• Layn Corp.（SoPure）
• Merisant（PureVia, Whole Earth）
• Morita Kagaku Kogyo Co., Ltd.
• Nutrinova（Celanese）
• PureCircle（now under Ingredion）
• Pyure Brands LLC
• Shandong Sunwin Stevia International Inc.
• SweeGen, Inc.
• Tate & Lyle PLC
• Truvia（Cargill brand）
• The Real Stevia Company

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有查询通用的 LLM 或特定于行业的 SLM，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 比赛

Global Steviol Glycosides Market to Reach US$6.6 Billion by 2030

The global market for Steviol Glycosides estimated at US$5.1 Billion in the year 2024, is expected to reach US$6.6 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Steviolbioside, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Stevioside segment is estimated at 5.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 7.6% CAGR

The Steviol Glycosides market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Steviol Glycosides Market - Key Trends & Drivers Summarized

What’s Boosting Demand for Steviol Glycosides as Natural Sweeteners?

Steviol glycosides-natural sweet compounds derived from the Stevia rebaudiana plant-are gaining rapid trust as sugar substitutes. Offering zero calories while maintaining high sweetness, they are increasingly used in beverages, confectioneries, dairy alternatives, and tabletop sweeteners. Manufacturers and governments are turning to stevia for sugar reduction to combat obesity and diabetes. This shift has positioned steviol glycosides as preferred natural ingredients in a clean-label food industry. The extraction industry has matured, with solvent-based and water-based processes yielding high-purity Rebaudioside A variants (e.g., Reb A, Reb D, Reb M). These refinements help overcome lingering taste concerns such as aftertastes or bitterness present in older stevia extracts.

Are Taste Enhancement and Formulation Technologies Evolving?

New taste modulation efforts-using mizzen blends of Reb M and Reb D-reduce bitterness and improve mouthfeel. Masking flavors, encapsulation techniques, and steep pH adjustments enable compatibility in acidic beverages and heat-stable applications. Clear syrups and blends are optimized for sparkling water, RTDs, and yogurt drinks. Encapsulation ensures uniform dissolution in dry mixes. Blends of steviol glycosides with other sweeteners (e.g., erythritol, allulose) create sugar-like sensory experiences, expanding product versatility.

Why Are Manufacturers Favoring Steviol Glycosides?

Health and regulatory mandates pushing sugar reduction in packaged foods and foods specifically for children have made stevia an essential ingredient. Consumer preferences skew toward natural, plant-based ingredients over synthetic ones. Foods marketed as ‘no added sugar’, ‘zero-calorie’, or ‘sugar-free’ rely on stevia for sweetening. Supply chain resilience has improved following controlled Stevia cultivation in major exporting countries. Brands benefit from FCC food-grade purity standards, achieving faster product approvals in regulated markets.

What’s Powering the Growth in the Steviol Glycosides Market?

The growth in the steviol glycosides market is driven by several factors related to expanding applications, taste advancements, and regulatory momentum. New high-purity Rebaudioside variants address earlier taste barriers, expanding adoption across beverage, dairy, and bakery. Increased investment in taste-masking and encapsulation technologies improves formulations. Public health initiatives and sugar taxes in key economies enhance demand. Stevia is receiving broad regulatory acceptance: GRAS status in the U.S., and approvals in the EU, India, and Latin America. Collaborative supply-chain partnerships among farmers, processors, and brands are strengthening traceability and consistency-critical for global food manufacturers.

SCOPE OF STUDY:

The report analyzes the Steviol Glycosides market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Steviolbioside, Stevioside, Rebaudioside A, Rebaudioside B); Processing Method (Fermentation-based Method, Farming-based Method); End-Use (Food & Beverages End-Use, Medicines End-Use, Chemicals End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• ADM (Archer Daniels Midland)
• Blue California
• Cargill, Incorporated
• DSM (Koninklijke DSM N.V.)
• Evolva
• Fujifilm Wako Pure Chemical Corporation
• GLG Life Tech Corp. (GL Stevia)
• Ingredion Incorporated
• Kerry Inc.
• Layn Corp. (SoPure)
• Merisant (PureVia, Whole Earth)
• Morita Kagaku Kogyo Co., Ltd.
• Nutrinova (Celanese)
• PureCircle (now under Ingredion)
• Pyure Brands LLC
• Shandong Sunwin Stevia International Inc.
• SweeGen, Inc.
• Tate & Lyle PLC
• Truvia (Cargill brand)
• The Real Stevia Company

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Steviol Glycosides - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Consumer Demand for Natural Sweeteners Drives Market for Steviol Glycosides
  • Health-Conscious Shift Away From Sugar and Artificial Sweeteners Sustains Growth
  • Regulatory Approvals Across Regions Expand Global Market Accessibility
  • Growing Use in Beverages, Bakery, and Dairy Applications Strengthens Commercial Demand
  • Product Reformulations in FMCG Brands Throw Spotlight on Stevia as a Clean-Label Ingredient
  • Taste Profile Improvements via Enzymatic Modification Enhance Consumer Acceptance
  • Demand From Diabetic and Calorie-Conscious Segments Spurs Functional Ingredient Adoption
  • Growth in Organic and Plant-Based Product Categories Aligns With Stevia's Natural Positioning
  • Stevia Blends With Other Sweeteners Enable Cost and Taste Optimization
  • Expansion of Beverage Startups and Health-Drink Lines Accelerates Use in Low-Calorie Formulations
  • Sustainable and Scalable Stevia Cultivation Supports Supply Chain Resilience
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Steviol Glycosides Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Steviol Glycosides by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Steviol Glycosides by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Steviol Glycosides by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Steviolbioside by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Steviolbioside by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Steviolbioside by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Stevioside by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Stevioside by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Stevioside by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Rebaudioside A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Rebaudioside A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Rebaudioside A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Rebaudioside B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Rebaudioside B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Rebaudioside B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Fermentation-based Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Fermentation-based Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Fermentation-based Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Farming-based Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Farming-based Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Farming-based Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Food & Beverages End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Food & Beverages End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Food & Beverages End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Medicines End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Medicines End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Medicines End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Chemicals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Chemicals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Chemicals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: China 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Steviol Glycosides by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Steviol Glycosides by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Steviol Glycosides by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: France 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Steviol Glycosides by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Steviol Glycosides by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Steviol Glycosides by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: India 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Steviol Glycosides by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Steviol Glycosides by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Steviol Glycosides by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Steviol Glycosides by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Steviol Glycosides by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Steviol Glycosides by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Steviol Glycosides Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Steviol Glycosides by Type - Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Steviol Glycosides by Type - Percentage Breakdown of Value Sales for Steviolbioside, Stevioside, Rebaudioside A and Rebaudioside B for the Years 2014, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Steviol Glycosides by Processing Method - Fermentation-based Method and Farming-based Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Steviol Glycosides by Processing Method - Percentage Breakdown of Value Sales for Fermentation-based Method and Farming-based Method for the Years 2014, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Steviol Glycosides by End-Use - Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Steviol Glycosides by End-Use - Percentage Breakdown of Value Sales for Food & Beverages End-Use, Medicines End-Use and Chemicals End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION